← Lakefront Biotherapeutics NV
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments For Depreciation And Amortisation Expense And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | — | — | — | — | — | — | — | — | $45.5m | $55.9m | — | |
| Profit or Loss | $54.0m | ($115.7m) | ($29.3m) | $149.8m | ($305.4m) | ($103.2m) | ($218.0m) | $211.7m | $74.1m | $320.9m | — | |
| Other Adjustments To Reconcile Profit Loss | — | — | — | — | $4.1m | — | — | — | — | — | — | |
| Adjustments For Share-Based Payments | $11.0m | $16.5m | $26.8m | $38.3m | $80.0m | $70.7m | $88.5m | $56.7m | $19.9m | $24.0m | — | |
| Change in working capital other than deferred income | ($10.9m) | ($12.9m) | $19.9m | $12.7m | ($146.1m) | $23.3m | ($32.3m) | ($31.4m) | ($61.4m) | $149.3m | ($964.3m) | |
| Cash used for other liabilities related to the acquisition of subsidiaries | — | — | — | — | — | — | ($28.2m) | — | ($3.6m) | ($1.8m) | — | |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | — | $7k | $0 | $0 | $49k | — | $739k | $2.4m | $3k | $462k | — | |
| Purchase of property, plant and equipment | ($4.5m) | ($5.3m) | ($10.4m) | ($22.4m) | ($42.5m) | ($54.2m) | ($27.4m) | ($18.7m) | ($16.7m) | ($13.7m) | — | |
| Adjustments For Gain Loss On Disposal Of Investments In Subsidiaries Joint Ventures And Associates | — | — | — | — | — | — | — | — | $52.5m | $1.1m | — | |
| Purchase of financial investments | — | — | $0 | ($4.8b) | ($4.6b) | — | ($2.7b) | ($3.4b) | ($3.3b) | ($3.5b) | — | |
| Investment income received related to current financial investments | — | — | $0 | $5.1m | $3.5m | $12k | $3.0m | $14.8m | $29.5m | $60.4m | — | |
| Sale of current financial investments | — | — | $0 | $1.1b | $5.4b | $2.1b | $1.6b | $3.5b | $3.7b | $3.7b | — | |
| Net cash flows generated from/used in (-) investing activities | ($7.3m) | ($549k) | ($15.9m) | ($3.8b) | $757.3m | $541.2m | ($1.2b) | $71.2m | $220.6m | $288.8m | — | |
| Payment of lease liabilities and other debts | — | ($65k) | ($5k) | ($5.1m) | ($6.2m) | ($7.2m) | ($8.2m) | ($6.8m) | ($4.9m) | ($3.3m) | — | |
| Net cash flows used in financing activities | $396.0m |
$353.4m
-10.77%
|
$287.9m
-18.53%
|
$1.3b
+364.00%
|
$22.0m
-98.35%
|
($3.9m)
-117.59%
|
($1.5m)
+61.64%
|
($5.0m)
-236.31%
|
($4.9m)
+1.54%
|
($3.3m)
+33.53%
|
— | |
| Increase/decrease (-) in cash and cash equivalents | — | $205.8m | $129.5m | $779.7m | $352.0m | $33.5m | ($1.7b) | ($339.8m) | ($104.4m) | $28.1m | — | |
| Cash and cash equivalents at beginning of year | $340.3m | $973.2m | $1.2b | $1.3b | $1.9b | $2.2b | $508.1m | $166.8m | $64.2m | $87.9m | $108.1m | |
| Effect of exchange rate differences on cash and cash equivalents | $4.8m | ($27.8m) | $10.1m | ($10.0m) | ($70.5m) | $56.8m | $22.3m | ($1.5m) | $1.8m | ($4.5m) | — | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Additional Financial Items | ||||||||||||
| Adjustments For Decrease Increase In Trade Account Receivable | ($13.0m) | ($27.7m) | $76k | $67.3m | ($177.2m) | ($79.9m) | $69.0m | ($39.1m) | ($31.1m) | $86.6m | — | |
| Adjustments For Income Tax Expense | — | — | — | — | $2.1m | $2.4m | $2.8m | $11.7m | ($1.7m) | ($18.1m) | — | |
| Adjustments For Increase Decrease In Trade Account Payable | $2.1m | $14.8m | ($20.0m) | ($79.9m) | $31.2m | $35.4m | ($2.1m) | $31.8m | ($53.4m) | $33.8m | — | |
| Adjustments For Unrealised Foreign Exchange Losses Gains | — | — | ($10.1m) | — | — | — | — | — | — | — | — | |
| General And Administrative Expense | $21.7m | $24.4m | $35.6m | $73.7m | $118.8m | $140.9m | $144.9m | $128.3m | $117.2m | $147.3m | — | |
| Goodwill | — | — | — | — | — | — | $69.8m | $69.6m | $70.0m | — | $0 | |
| Income Taxes Paid Refund Classified As Operating Activities | $1.8m | $199k | $8k | $57k | $1.4m | $684k | $4.4m | $8.2m | ($406k) | $372k | — | |
| Interest Paid Classified As Operating Activities | $47k | $273k | $1.1m | $1.2m | $9.0m | $12.5m | $12.5m | $3.8m | $689k | $464k | — | |
| Interest Received Classified As Operating Activities | $1.1m | $1.3m | $4.6m | $7.9m | $10.1m | $2.9m | $4.8m | $69.9m | $97.5m | $51.3m | — | |
| Payments Of Lease Liabilities Classified As Financing Activities | — | — | — | $5.1m | $6.2m | $7.2m | $8.2m | $6.8m | $4.9m | $3.3m | — | |
| Proceeds From Disposal Or Maturity Of Availableforsale Financial Assets | — | $372k | $2.4m | $82k | $6.6m | $4.0m | — | — | — | — | — | |
| Proceeds From Issuing Shares | $392.1m | $363.9m | $296.2m | $960.1m | $0 | — | — | — | — | — | — | |
| Purchase Of Intangible Assets Classified As Investing Activities | $332k | $2.1m | $3.3m | $23.3m | $48.8m | $3.7m | $9.6m | $567k | $65.4m | $155k | — | |
| Net profit / (loss) (-) | $54.0m | ($115.7m) | ($29.3m) | $149.8m | ($305.4m) | ($103.2m) | ($218.0m) | $211.7m | $74.1m | $320.9m | — | |
| Increase in provisions | $7k | $1k | — | — | — | — | — | — | — | $45.5m | — | |
| Adjustment for non-cash transactions | ($47.5m) | $48.3m | $21.8m | $248.0m | $230.7m | $57.7m | $117.3m | $99.3m | ($4.9m) | $127.2m | — | |
| Adjustment for items to disclose under investing and financing cash flows | ($14k) | — | ($668k) | ($5.1m) | ($2.5m) | ($28.8m) | ($3.8m) | ($16.7m) | ($76.2m) | ($42.3m) | — | |
| Decrease in deferred income | — | — | — | — | ($207.8m) | ($453.7m) | ($383.6m) | ($661.1m) | ($255.5m) | ($1.1b) | — | |
| Cash used in operations | $240.1m | ($147.9m) | ($146.0m) | $3.2b | ($427.0m) | ($493.5m) | ($488.5m) | ($463.9m) | ($417.3m) | ($307.9m) | — | |
| Purchase of and expenditure in intangible fixed assets | ($332k) | ($2.1m) | ($3.3m) | ($23.3m) | ($48.8m) | ($3.7m) | ($9.6m) | ($567k) | ($65.4m) | ($155k) | — | |
| Cash out from disposal of subsidiaries, net of cash disposed of | — | — | — | — | — | — | — | — | ($8.9m) | $19.4m | — | |
| Cash out from acquisition of subsidiaries, net of cash acquired | — | — | — | — | — | — | ($115.3m) | ($7.0m) | — | — | — | |
| Cash advances and loans to third parties | — | — | — | — | — | — | ($10.0m) | — | — | ($20.0m) | — | |
| Acquisition of financial assets held at fair value | — | — | — | — | — | — | — | ($14.0m) | ($36.9m) | — | — | |
| Proceeds from capital and share premium increases from exercise of subscription rights | — | — | — | — | $28.3m | $3.3m | $6.7m | $1.8m | — | — | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.